Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRuffer Regulatory News (RICA)

Share Price Information for Ruffer (RICA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 271.50
Bid: 269.00
Ask: 270.50
Change: 0.00 (0.00%)
Spread: 1.50 (0.558%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 271.50
RICA Live PriceLast checked at -
Ruffer Investment Company is an Investment Trust

To achieve capital and income return of twice the Bank of England base rate by investing through internationally listed securities and bonds.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

RICL Monthly Investment Report August 2019

9 Sep 2019 12:10

RNS Number : 6716L
Ruffer Investment Company Limited
09 September 2019
 

RUFFER INVESTMENT COMPANY LIMITED

(a closed-ended investment company incorporated in Guernsey with registration number 41996)

LEI 21380068AHZKY7MKNO47

 

 

Attached is a link to the Investment Monthly Report for August 2019.

 

http://www.rns-pdf.londonstockexchange.com/rns/6716L_1-2019-9-9.pdf

 

During August, the net asset value of the Company rose by 0.6%. This compares with a fall of 3.6% in the FTSE All-Share index.

 

With economic data deteriorating further, most notably in Germany and China, and no early end in sight to the US-China trade spat, August witnessed a further stage in the seemingly unstoppable bull market in government bonds. Negative yielding government debt hit a new record of $17 trillion, and the yield on 30 year US government stock temporarily went below 2%. With gold's zero yield suddenly not so anomalous the yellow metal's price rose 8% in US dollar terms, and thus in a month of generally falling equity markets, the portfolio's gold-related investments and inflation-linked bonds were the main contributors to August's positive return.

 

Where to next? Having cut interest rates by 0.25% at the end of July the US Federal Reserve's Jackson Hole symposium gave little incremental clue as to the future path of interest rates. While financial markets have been quick to price in further rate reductions, the continued robustness of the US consumer, buoyed by continued jobs growth and rising wages, shows clearly the Fed's dilemma, even before taking into account the sustained volley of uncomplimentary tweets from the White House. Elsewhere, a further driver to the narrative of falling yields has been hopes for another big monetary bazooka from the European Central Bank later in September.

 

Regular readers will be well aware of our view that come the next economic slowdown fiscal policy will have to share in the heavy lifting, and with the UK government's 'magic money tree' coming to resemble a veritable forest, the UK seems set to lead in this respect. With a snap election seemingly avoided in Italy then some fiscal relaxation there seems reasonable to expect. Even in Germany, should the economy worsen further, there is talk of higher government spending, especially if it can be executed under the cover of climate change or a green agenda. For us all of these roads lead to the risk of higher inflation.

 

One final puzzle for us has been the continued robust performance of credit as an asset class. With all the talk of economic deceleration, let alone recession, one might have expected wobbles in credit as investors move to price in the risk of higher borrowing spreads or a default cycle. As yet, however, the credit market has paid much more attention to the story of lower rates than to that of lower activity. So far the poorly performing parts of the credit sphere remain idiosyncratic, but we suspect it is only a matter of time before concerns spread, and the portfolio's credit protections have their moment.

 

 

 

 

Enquiries:

 

Praxis Fund Services Limited

Gail Adams

DDI: +44(0)1481 755584

Email: ric@praxisifm.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCCKCDDKBKDQCK
Date   Source Headline
6th Apr 20233:58 pmRNSIssue of Equity and Total Voting Rights
5th Apr 20231:58 pmRNSNet Asset Value(s)
3rd Apr 20233:11 pmRNSNet Asset Value(s)
31st Mar 20233:54 pmRNSTotal Voting Rights
30th Mar 20235:12 pmRNSIssue of Equity and Total Voting Rights
29th Mar 20233:01 pmRNSNet Asset Value(s)
24th Mar 20235:23 pmRNSBlock listing Interim Review
23rd Mar 20234:38 pmRNSIssue of Equity and Total Voting Rights
22nd Mar 20235:10 pmRNSIssue of Equity and Total Voting Rights
22nd Mar 20233:13 pmRNSNet Asset Value(s)
22nd Mar 202311:37 amRNSDirector Declaration
16th Mar 20235:16 pmRNSIssue of Equity and Total Voting Rights
15th Mar 20235:53 pmRNSIssue of Equity and Total Voting Rights
15th Mar 20233:43 pmRNSNet Asset Value(s)
13th Mar 20237:00 amRNSBlock listing Interim Review
9th Mar 20237:00 amRNSMonthly Investment Report - February 2023
8th Mar 20233:03 pmRNSNet Asset Value(s)
2nd Mar 20233:38 pmRNSIssue of Equity and Total Voting Rights
1st Mar 20232:52 pmRNSNet Asset Value(s)
28th Feb 20237:00 amRNSTotal Voting Rights
23rd Feb 20233:41 pmRNSIssue of Equity and Total Voting Rights
22nd Feb 20233:42 pmRNSNet Asset Value(s)
22nd Feb 20237:01 amRNSDividend Declaration
22nd Feb 20237:00 amRNSHalf-year Report
16th Feb 20234:44 pmRNSIssue of Equity and Total Voting Rights
15th Feb 20234:31 pmRNSIssue of Equity and Total Voting Rights
15th Feb 20233:08 pmRNSNet Asset Value(s)
13th Feb 20239:00 amRNSChange of Registered Office
10th Feb 20237:00 amRNSMonthly Investment Report - January 2023
8th Feb 202312:53 pmRNSNet Asset Value(s)
2nd Feb 20235:44 pmRNSIssue of Equity and Total Voting Rights
1st Feb 202312:14 pmRNSNet Asset Value(s)
31st Jan 20234:00 pmRNSTotal Voting Rights
26th Jan 20234:45 pmRNSIssue of Equity & Total Voting Rights
25th Jan 202312:29 pmRNSNet Asset Value(s)
19th Jan 20234:33 pmRNSIssue of Equity and Total Voting Rights
18th Jan 202312:55 pmRNSNet Asset Value(s)
16th Jan 20237:00 amRNSInvestment Manager's Period End Review
12th Jan 20234:32 pmRNSIssue of Equity & Total Voting Rights
12th Jan 20234:00 pmRNSMonthly Investment Report - December 2022
11th Jan 202311:07 amRNSNet Asset Value(s)
5th Jan 20233:43 pmRNSIssue of Equity and Total Voting Rights
4th Jan 20234:06 pmRNSIssue of Equity and Total Voting Rights
4th Jan 20231:06 pmRNSNet Asset Value(s)
3rd Jan 20232:09 pmRNSTotal Voting Rights
3rd Jan 202312:06 pmRNSNet Asset Value(s)
28th Dec 20223:22 pmRNSNet Asset Value(s)
22nd Dec 20225:04 pmRNSIssue of Equity and Total Voting Rights
21st Dec 20225:26 pmRNSIssue of Equity
21st Dec 20221:45 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.